Zita Cavalieri

459 citations
11 papers · 313 indexed · h-index 6
Topics
Carcinogens and Genotoxicity Assessment (2 papers)Cancer Genomics and Diagnostics (2 papers)Nicotinic Acetylcholine Receptors Study (2 papers)
Partner nations
ItalyRussia

In The Last Decade

Zita Cavalieri

9 papers receiving 301 citations

Peers

Zita Cavalieri
Comparison fields: 5 of 58
  • Cancer Research 179
  • Molecular Biology 134
  • Plant Science 92
  • Health, Toxicology and Mutagenesis 59
  • Oncology 47
Replace Peter Maimon Ross with:
Peter Maimon Ross United States
Gengming Huang United States
Ilona Schreck Germany
Kenneth S. Ramos United States
Richard A. Spellman United States
Fumio Matsumura United States
Mohammed A. Hannan Saudi Arabia
Tomotoshi Akematsu Japan
Hamada A. Mokhlis Egypt
Zita Cavalieri relative to Peter Maimon Ross United States Peter Maimon Ross's profile →
Citations per field
00.5×
Peter Maimon Ross · 1×
Citations per year

Countries citing papers authored by Zita Cavalieri

Since Specialization
Citations

This map shows the geographic impact of Zita Cavalieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zita Cavalieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zita Cavalieri more than expected).

Fields of papers citing papers by Zita Cavalieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zita Cavalieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zita Cavalieri. The network helps show where Zita Cavalieri may publish in the future.

Co-authorship network of co-authors of Zita Cavalieri

This figure shows the co-authorship network connecting the top 25 collaborators of Zita Cavalieri. A scholar is included among the top collaborators of Zita Cavalieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zita Cavalieri. Zita Cavalieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 45
5 0
6 36
7 58
8 1
9 8
10 53
11 109

About Zita Cavalieri

Zita Cavalieri is a scholar working on Cancer Research, Pharmaceutical Science and Pharmacology, having authored 11 papers that have together received 313 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (2 papers), Cancer Genomics and Diagnostics (2 papers) and Nicotinic Acetylcholine Receptors Study (2 papers). The work is most often cited by research in Cancer Research (179 citations), Chemical Health and Safety (5 citations) and Health, Toxicology and Mutagenesis (59 citations). Zita Cavalieri has collaborated with scholars based in Italy and Russia. Frequent co-authors include S. Bonatti, Silvia Viaggi, Stefano Bonassi, Alberto Abbondandolo, Marcella De Ferrari, M. Artuso, Patrizia Russo, Alessia Grozio, Alfredo Cesario and Laura Paleari. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026